Evidence map›Paper›PMID 27254258›Full record

ArticleExperimental and clinical psychopharmacology2016

Buspirone reduces sexual risk-taking intent but not cocaine self-administration.

B Levi Bolin, Joshua A Lile, Katherine R Marks, Joshua S Beckmann, Craig R Rush, William W Stoops

Open access · hybridAbstract read
In one paragraph

Article in Experimental and clinical psychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Review
  9. Article
  10. Immunopharmacotherapies for Treating Opioid Use Disorder.Trends in pharmacological sciences · 2018
    Review
  11. Article
  12. Review
  13. Review
  14. Effects of Acute and Chronic Treatments with Dopamine DThe Journal of pharmacology and experimental therapeutics · 2017
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

B Levi BolinDepartment of Behavioral Science, University of Kentucky College of Medicine.
Joshua A LileDepartment of Behavioral Science, University of Kentucky College of Medicine.
Katherine R MarksDepartment of Psychology, University of Kentucky College of Arts and Sciences.
Joshua S BeckmannDepartment of Psychology, University of Kentucky College of Arts and Sciences.
Craig R RushDepartment of Behavioral Science, University of Kentucky College of Medicine.
William W StoopsDepartment of Behavioral Science, University of Kentucky College of Medicine.
University of Kentucky · US

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
Research Training in Drug Abuse BehaviorT32DA035200 · NIDA · UNIVERSITY OF KENTUCKY · PI CRAIG R RUSH, William Walton Stoops · 2013 to 2026
$4.4M
Kentucky Center for Clinical and Translational ScienceTL1TR000115 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$518k
Medications Development for Cannabis-Use Disorders: Clinical StudiesK02DA031766 · NIDA · UNIVERSITY OF KENTUCKY · PI LILE, JOSHUA ANTHONY · 2011 to 2015
$487k
A Human Laboratory Study to Investigate Buspirone for Cocaine Use DisordersR21DA034095 · NIDA · UNIVERSITY OF KENTUCKY · PI STOOPS, WILLIAM WALTON · 2012 to 2013
$363k
NCATS NIH HHS TL1 TR000115NCATS NIH HHS UL1 TR000117NIDA NIH HHS K02 DA031766NIDA NIH HHS R21 DA034095NIDA NIH HHS T32 DA035200
6 · The paper itself

Abstract

Impulsive sexual decision-making may underlie sexual risk-taking behavior that contributes to the disproportionately high prevalence of HIV infection among cocaine users. Delay-discounting procedures measure impulsive decision-making and may provide insight into the underlying mechanisms of sexual risk-taking behavior. The anxiolytic drug buspirone reduces delay discounting in rats and blunts the reinforcing effects of cocaine in some preclinical studies suggesting that it might have utility in the treatment of cocaine-use disorders. This study determined whether buspirone mitigates impulsive risky sexual decision-making in cocaine users on a sexual delay-discounting procedure. The effects of buspirone maintenance on the abuse-related and physiological effects of cocaine were also tested. Nine (N = 9) current cocaine users completed a repeated-measures, inpatient protocol in which sexual delay discounting was assessed after 3 days of maintenance on placebo and buspirone (30 mg/day) in counterbalanced order. The reinforcing, subject-rated, and physiological effects of placebo and intranasal cocaine (15 and 45 mg) were also assessed during buspirone and placebo maintenance. Buspirone increased the likelihood of condom use for hypothetical sexual partners that were categorized as most likely to have a sexually transmitted infection and least sexually desirable. Cocaine functioned as a reinforcer and increased positive subjective effects ratings, but buspirone maintenance did not impact these effects of cocaine. Buspirone was also safe and tolerable when combined with cocaine and may have blunted some its cardiovascular effects. The results from the sexual delay-discounting procedure indicate that buspirone may reduce preference for riskier sex in cocaine users. (PsycINFO Database Record

Indexed as

AdultBuspironeCocaineCocaine-Related DisordersCondomsCross-Over StudiesDelay DiscountingDouble-Blind MethodFemaleHumansImpulsive BehaviorMaleMiddle AgedReinforcement, PsychologyRisk-TakingSelf AdministrationBuspironeCocaine

Identifiers

PMID27254258
PMCPMC4896094
OpenAlexW2414290621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.